High-throughput approaches to measuring cell death

Cold Spring Harbor Protocols

Volumn 2014, Issue 6, 2014, Pages 591-601

  Saunders, Darren N ^a,b   Falkenberg, Katrina J ^c,d   Simpson, Kaylene J ^c,d  

^a GARVAN INSTITUTE OF MEDICAL RESEARCH   (Australia)

^b UNIVERSITY OF NEW SOUTH WALES   (Australia)

^c PETER MACCALLUM CANCER CENTRE   (Australia)

^d UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATE; SMALL INTERFERING RNA; FLUORESCENT DYE;

ADHERENT CELL; APOPTOSIS ASSAY; ARTICLE; AUTOMATION; BIOINFORMATICS; BIOSTATISTICS; CELL ASSAY; CELL COUNT; CELL DEATH; CELL DENSITY; CELL PROLIFERATION; CELL SUSPENSION; DRUG MECHANISM; DRUG SENSITIVITY; HIGH CONTENT IMAGING; HIGH THROUGHPUT SCREENING; IMAGE ANALYSIS; MICROPLATE READER; PHENOTYPE; PLATE READER ASSAY; REPRODUCIBILITY; SIGNAL NOISE RATIO; CELL LINE; CELL SURVIVAL; CYTOLOGY; HUMAN; PROCEDURES; STAINING;

CELL DEATH; CELL LINE; CELL SURVIVAL; CYTOLOGICAL TECHNIQUES; FLUORESCENT DYES; HIGH-THROUGHPUT SCREENING ASSAYS; HUMANS; STAINING AND LABELING;

EID: 84922325505     PISSN: 19403402     EISSN: 15596095     Source Type: Journal    
DOI: 10.1101/pdb.top072561     Document Type: Article

References (23)

1. Bauer JA, Ye F, Marshall CB, Lehmann BD, Pendleton CS, Shyr Y, Arteaga CL, Pietenpol JA. 2010. RNA interference (RNAi) screening approach identifies agents that enhance paclitaxel activity in breast cancer cells. Breast Cancer Res 12: R41.
2. Birmingham A, Selfors LM, Forster T, Wrobel D, Kennedy CJ, Shanks E, Santoyo-Lopez J, Dunican DJ, Long A, Kelleher D, et al. 2009. Statistical methods for analysis of high-throughput RNA interference screens. Nat Methods 6: 569-575.
3. Boutros M, Kiger AA, Armknecht S, Kerr K, Hild M, Koch B, Haas SA, Paro R, Perrimon N. 2004. Genome-wide RNAi analysis of growth and viability in Drosophila cells. Science 303: 832-835.
4. Brunelle JK, Zhang B. 2010. Apoptosis assays for quantifying the bioactivity of anticancer drug products. Drug Resist Updat 13: 172-179.
5. Buenz EJ, Limburg PJ, Howe CL. 2007. A high-throughput 3-parameter flow cytometry-based cell death assay. Cytometry A 71: 170-173.
6. De Pasquale B, Righetti G, Menotti A. 1990. L-carnitine for the treatment of acute myocardial infarct. Cardiologia 35: 591-596.
7. Dompe N, Rivers CS, Li L, Cordes S, Schwickart M, Punnoose EA, Amler L, Seshagiri S, Tang J, Modrusan Z, et al. 2011. A whole-genome RNAi screen identifies an 8q22 gene cluster that inhibits death receptor-mediated apoptosis. Proc Natl Acad Sci 108: E943-E951.
8. Falkenberg KJ, Saunders DN, Simpson KJ. 2014. A high-throughput multiplex cell death assay using an RNAi screening approach. Cold Spring Harb Protoc doi: 10.1101/pdb.prot080267.
9. Galluzzi L, Morselli E, Vitale I, Kepp O, Senovilla L, Criollo A, Servant N, Paccard C, Hupe P, Robert T, et al. 2010. miR-181a and miR- 630 regulate cisplatin-induced cancer cell death. Cancer Res 70: 1793-1803.
10. Gilbert DF, Erdmann G, Zhang X, Fritzsche A, Demir K, Jaedicke A, Muehlenberg K, Wanker EE, Boutros M. 2011. A novel multiplex cell viability assay for high-throughput RNAi screening. PLoS ONE 6: e28338.
11. Luo J, Emanuele MJ, Li D, Creighton CJ, Schlabach MR, Westbrook TF, Wong KK, Elledge SJ. 2009. A genome-wide RNAi screen identifies multiple synthetic lethal interactions with the Ras oncogene. Cell 137: 835-848.
12. MacDonald ML, Lamerdin J, Owens S, Keon BH, Bilter GK, Shang Z, Huang Z, Yu H, Dias J, Minami T, et al. 2006. Identifying off-target effects and hidden phenotypes of drugs in human cells. Nat Chem Biol 2: 329-337.
13. Neumann B, Walter T, Heriche JK, Bulkescher J, Erfle H, Conrad C, Rogers P, Poser I, Held M, Liebel U, et al. 2010. Phenotypic profiling of the human genome by time-lapse microscopy reveals cell division genes. Nature 464: 721-727.
14. Nguyen DG, Wolff KC, Yin H, Caldwell JS, Kuhen KL. 2006. “UnPAKing” human immunodeficiency virus (HIV) replication: Using small interfering RNA screening to identify novel cofactors and elucidate the role of group I PAKs in HIV infection. J Virol 80: 130-137.
15. Niles AL, Moravec RA, Riss TL. 2009. In vitro viability and cytotoxicity testing and same-well multi-parametric combinations for high throughput screening. Curr Chem Genomics 3: 33-41.
16. Parrish JZ, Xue D. 2003. Functional genomic analysis of apoptotic DNA degradation in C. elegans. Mol Cell 11: 987-996.
17. Poon SS, Wong JT, Saunders DN, Ma QC, McKinney S, Fee J, Aparicio SA. 2008. Intensity calibration and automated cell cycle gating for highthroughput image-based siRNA screens of mammalian cells. Cytometry A 73: 904-917.
18. Potratz JC, Saunders DN, Wai DH, Ng TL, McKinney SE, Carboni JM, Gottardis MM, Triche TJ, Jurgens H, Pollak MN, et al. 2010. Synthetic lethality screens reveal RPS6 and MST1R as modifiers of insulin-like growth factor-1 receptor inhibitor activity in childhood sarcomas. Cancer Res 70: 8770-8781.
19. Qiu BY, Turner N, Li YY, Gu M, Huang MW, Wu F, Pang T, Nan FJ, Ye JM, Li JY, et al. 2010. High-throughput assay for modulators of mitochondrial membrane potential identifies a novel compound with beneficial effects on db/db mice. Diabetes 59: 256-265.
20. Simpson KJ, Selfors LM, Bui J, Reynolds A, Leake D, Khvorova A, Brugge JS. 2008. Identification of genes that regulate epithelial cell migration using an siRNA screening approach. Nat Cell Biol 10: 1027-1038.
21. Snijder B, Sacher R, Ramo P, Liberali P, Mench K, Wolfrum N, Burleigh L, Scott CC, Verheije MH, Mercer J, et al. 2012. Single-cell analysis of population context advances RNAi screening at multiple levels. Mol Syst Biol 8: 579.
22. Stec E, Locco L, Szymanski S, Bartz SR, Toniatti C, Needham RH, Palmieri A, Carleton M, Cleary MA, Jackson AL, et al. 2012. A multiplexed siRNA screening strategy to identify genes in the PARP pathway. J Biomol Screen 17: 1316-1328.
23. Tsui M, Xie T, Orth JD, Carpenter AE, Rudnicki S, Kim S, Shamu CE, Mitchison TJ. 2009. An intermittent live cell imaging screen for siRNA enhancers and suppressors of a kinesin-5 inhibitor. PLoS ONE 4: e7339.